Brief: PCI Biotech Q3 Operating Loss NOK 10.5 Mln
Nov 28 (Reuters) - PCI BIOTECH HOLDING ASA PCIB.OL :
* Q3 OPERATING LOSS NOK 10.5 MILLION VERSUS LOSS NOK 9.5
MILLION
YEAR AGO
* Q3 PRE-TAX LOSS NOK 10.3 MILLION VERSUS LOSS NOK 9.3
MILLION
YEAR AGO
Source text for Eikon: ID:nNDL7mJnLY
Further company coverage: PCIB.OL
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process